|4Apr 19, 4:10 PM ET

Leavitt Equity Partners II, L.P. 4

4 · P3 Health Partners Inc. · Filed Apr 19, 2023

Insider Transaction Report

Form 4
Period: 2023-04-06
Transactions
  • Award

    Warrant

    2023-04-06+670,841670,841 total(indirect: By Leavitt Equity Partners II, L.P.)
    Exercise: $1.13Exp: 2028-04-05Class A Common Stock (670,841 underlying)
  • Award

    Class A Common Stock

    2023-04-06+8,944,5438,944,543 total(indirect: By Leavitt Equity Partners III, L.P.)
  • Award

    Class A Common Stock

    2023-04-06+894,454894,454 total(indirect: By Leavitt Equity Partners II, L.P.)
  • Award

    Warrant

    2023-04-06+6,708,4076,708,407 total(indirect: By Leavitt Equity Partners III, L.P.)
    Exercise: $1.13Exp: 2028-04-05Class A Common Stock (6,708,407 underlying)
Holdings
  • Class V Common Stock

    (indirect: Leavitt Equity Partners II, L.P.)
    3,758,130
Footnotes (3)
  • [F1]The reported securities were issued in connection with the Issuer's sale of 8,944,543 Units purchased by the Reporting Person for $1.1938 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) 0.75 of a warrant to purchase one share of Class A Common Stock.
  • [F2]The reported securities were issued in connection with the Issuer's sale of 894,454 Units purchased by the Reporting Person for $1.1938 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) 0.75 of a warrant to purchase one share of Class A Common Stock.
  • [F3]Exercisable Immediately.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION